Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo

p53 Expression Helps Identify High Risk Oral Tongue Premalignant Lesions and Correlates with Patterns of Invasive Tumour Front and Tumour Depth in Oral Tongue Squamous Cell Carcinoma Cases

(2016) Thangaraj Soundara Viveka et al.   Asian Pacific Journal of Cancer Prevention

Enhanced anti-tumor activity and reduced toxicity by combination andrographolide and bleomycin in ascitic tumor-bearing mice

(2016) Huizhen Guo et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Tumor suppressor p53 and its mutants in cancer metabolism

(2015) Juan Liu et al.   CANCER LETTERS

Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma

(2015) Walid Zedan et al.   Diagnostic Pathology

Epidemiology of Oral Cancer in Asia in the Past Decade- An Update (2000-2012)

(2014) Sree Vidya Krishna Rao et al.   Asian Pacific Journal of Cancer Prevention

Association of Ki-67 antigen and p53 protein at invasive tumor front of oral squamous cell carcinoma

(2014) Akhilesh Chandra et al.   Indian Journal of Pathology and Microbiology

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Andrographolide Sensitizes the Cytotoxicity of Human Colorectal Carcinoma Cells Toward Cisplatin via Enhancing Apoptosis Pathways In Vitro and In Vivo

(2014) Hui-Hsuan Lin et al.   TOXICOLOGICAL SCIENCES

Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells

(2012) Jing Zhou et al.   Autophagy

Survival Pattern and Prognostic Factors of Patients With Squamous Cell Carcinoma of the Tongue: A Retrospective Analysis of 210 Cases

(2012) Wang Ling et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Andrographolide induces apoptosis in B16F-10 melanoma cells by inhibiting NF-κB-mediated bcl-2 activation and modulating p53-induced caspase-3 gene expression

(2011) P. Pratheeshkumar et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Andrographolide Inhibits Oral Squamous Cell Carcinogenesis through NF-κB Inactivation

(2011) L.-J. Wang et al.   JOURNAL OF DENTAL RESEARCH

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin

(2009) Jing Zhou et al.   BIOCHEMICAL PHARMACOLOGY